Digital health funding for COVID-19 vaccine deployment across four major donor agencies.


Journal

The Lancet. Digital health
ISSN: 2589-7500
Titre abrégé: Lancet Digit Health
Pays: England
ID NLM: 101751302

Informations de publication

Date de publication:
09 2023
Historique:
received: 10 11 2022
revised: 10 04 2023
accepted: 11 07 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 25 8 2023
Statut: ppublish

Résumé

The international response to the COVID-19 pandemic provided opportunities for countries to use digital technologies for vaccine deployment and associated activities, but misaligned digital investments could weaken or fragment national systems. In this review of 311 funding applications from 120 country governments to four donor agencies (UNICEF; Gavi, the Vaccine Alliance; the Global Fund to Fight AIDS, Tuberculosis and Malaria; and the World Bank) up to May 1, 2022, we found that 272 (87%) of the applications included at least one digital aspect and that substantial funding has been dedicated towards digital aspects from donors. The majority of digital aspects concerned immunisation information systems, vaccine acceptance and uptake, and COVID-19 surveillance. As the global community sets its sights on a COVID-19-free world, continued coordinated investments in digital health and health information systems for pandemic preparedness and response will be key to strengthening the resilience of health systems.

Identifiants

pubmed: 37625897
pii: S2589-7500(23)00134-6
doi: 10.1016/S2589-7500(23)00134-6
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e627-e631

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Auteurs

Daniel Helldén (D)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden. Electronic address: daniel.hellden@ki.se.

Sophia Tesfaye (S)

Gavi, the Vaccine Alliance, Geneva, Switzerland.

Carine Gachen (C)

Gavi, the Vaccine Alliance, Geneva, Switzerland.

Ann Lindstrand (A)

World Health Organization, Geneva, Switzerland.

Karin Källander (K)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden; UNICEF, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH